The first BioAtla trade was made in Q4 2021.
Since then Jim Simons bought shares eight more times and sold shares on ten occasions. The investor completely sold their stake between Q4 2025 and Q2 2026.
Avg closing price
Price range
Sold -10.2k shares
Q2 2026
Avg closing price
$4.23
Price range
$3.31
-
$6.73
Sold 27.8% shares (-3.93k shares)
Q1 2026
Avg closing price
$11.70
Price range
$7.06
-
$26.71
Sold 11.7% shares (-1.87k shares)
Q4 2025
Avg closing price
$39.21
Price range
$28.39
-
$61.00
Increased shares by 6.2% (+928 shares)
Q3 2025
Avg closing price
$23.09
Price range
$16.50
-
$38.75
Increased shares by 1.3% (+188 shares)
Q2 2025
Avg closing price
$20.28
Price range
$13.34
-
$27.90
Sold 10.2% shares (-1.69k shares)
Q1 2025
Avg closing price
$21.39
Price range
$15.25
-
$33.90
Increased shares by 62.2% (+6.36k shares)
Q4 2024
Avg closing price
$83.92
Price range
$29.50
-
$118.50
Sold 18.2% shares (-2.28k shares)
Q3 2024
Avg closing price
$83.85
Price range
$58.50
-
$102.50
Sold 37.2% shares (-7.42k shares)
Q2 2024
Avg closing price
$118.98
Price range
$68.50
-
$196.00
Increased shares by 0.9% (+176 shares)
Q1 2024
Avg closing price
$124.24
Price range
$94.00
-
$173.00
Increased shares by 57.9% (+7.25k shares)
Q4 2023
Avg closing price
$86.68
Price range
$63.50
-
$159.00
Sold 9.1% shares (-1.25k shares)
Q3 2023
Avg closing price
$127.45
Price range
$85.00
-
$153.50
Increased shares by 49.9% (+4.58k shares)
Q2 2023
Avg closing price
$171.99
Price range
$141.50
-
$193.50
Sold 4.3% shares (-416 shares)
Q1 2023
Avg closing price
$180.11
Price range
$115.00
-
$412.50
Sold 15.2% shares (-1.72k shares)
Q4 2022
Avg closing price
$414.87
Price range
$314.50
-
$550.50
Sold 27.5% shares (-4.3k shares)
Q3 2022
Avg closing price
$327.35
Price range
$147.00
-
$593.50
Increased shares by 45.5% (+4.88k shares)
Q2 2022
Avg closing price
$159.15
Price range
$106.50
-
$269.00
Increased shares by 656.6% (+9.31k shares)
Q1 2022